tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
C4 Therapeutics initiated with an Overweight at Barclays
PremiumThe FlyC4 Therapeutics initiated with an Overweight at Barclays
11d ago
C4 Therapeutics initiated with an Overweight at Barclays
Premium
The Fly
C4 Therapeutics initiated with an Overweight at Barclays
12d ago
C4 Therapeutics: Promising Growth and Competitive Edge with TORPEDO Platform and Strategic Partnerships
Premium
Ratings
C4 Therapeutics: Promising Growth and Competitive Edge with TORPEDO Platform and Strategic Partnerships
13d ago
C4 Therapeutics initiated with a Buy at Guggenheim
PremiumThe FlyC4 Therapeutics initiated with a Buy at Guggenheim
25d ago
C4 Therapeutics to present data from Phase 1 trial of cemsidomide
Premium
The Fly
C4 Therapeutics to present data from Phase 1 trial of cemsidomide
25d ago
C4 Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
C4 Therapeutics Reports Q2 2025 Financial Results
2M ago
C4 Therapeutics Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsC4 Therapeutics Reports Q1 2025 Financial Results
5M ago
C4 Therapeutics Updates on Cemsidomide Clinical Trial
Premium
Company Announcements
C4 Therapeutics Updates on Cemsidomide Clinical Trial
5M ago
C4 Therapeutics reports Q1 EPS (37c), consensus (42c)
Premium
The Fly
C4 Therapeutics reports Q1 EPS (37c), consensus (42c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100